Johns Hopkins spin-out GreyBug raises $1.5m in series A whilst announcing new CEO.

GreyBug, a life sciences company focused on developing eye disease treatments, announce both $1.5m series A and a new chief executive (CEO).

Michael O’Rourke, an 18-year veteran in ophthalmic leadership and commercialisation and a former member of GreyBug’s scientific advisory board, takes the helm as president and CEO of the Johns Hopkins University spin-out.

He comes in as the firm closed $1.5m in venture backing in a series A round supported by the Maryland Venture Fund, the Abell Foundation, and…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?